Biosimilars

All the posts published.

pCPA Under Consideration Backlog Starting to Form

December 9, 2020
-
Market Access News
-
Posted by MORSE
Read More →
Read More →

Some Positive Indicators as Number of Files Under Consideration Remains Flat – June 2020

July 28, 2020
-
Market Access News
-
Posted by MORSE
Read More →
Read More →

No Files Completed or Closed by the pCPA – May 2020

June 23, 2020
-
Market Access News
-
Posted by MORSE
Read More →
Read More →

Early Insights into pCPA Prioritization

May 22, 2020
-
Market Access News
-
Posted by MORSE
Read More →
Read More →

New pCPA Website & Available Data

April 7, 2020
-
Market Access News
-
Posted by MORSE
Read More →
Read More →

Number of active negotiations (34) at lowest point since March 2017

December 6, 2019
-
Market Access News
-
Posted by MORSE
Read More →
Read More →

Summary of the CADTH Drug Portfolio Information Session November 2019

December 2, 2019
-
Market Access News
-
Posted by MORSE
Read More →
Read More →

The workload at pCPA appears to have stabilized over 2019

November 14, 2019
-
Market Access News
-
Posted by MORSE
Read More →
Read More →

Average Time Under pCPA Consideration Below 30 Days for the 3rd Consecutive Month

October 16, 2019
-
Market Access News
-
Posted by MORSE
Read More →
Read More →

15 Oncology Files either Completed, Initiated or new Under Consideration

September 10, 2019
-
Market Access News
-
Posted by MORSE
Read More →
Read More →

pCPA Closing More Negotiations Without Agreements

August 6, 2019
-
Market Access News
-
Posted by MORSE Team
Read More →
Read More →

The pCPA Initiates Negotiations for a Second “Group” of Oncology Biosimilars

June 18, 2019
-
Market Access News
-
Posted by MORSE Team
Read More →
Read More →

Summary of PMPRB Webinar on Meds Entry Watch, 2017

February 27, 2019
-
Market Access News
-
Posted by MORSE Team
Read More →
Read More →

BC Pharmacare Now Transitioning Patients on Copaxone® to GLATECT™

November 29, 2018
-
Market Access News
-
Posted by MORSE Team
Read More →
Read More →

Summary of pCPA’s Webinar on Biologics Policy Directions & pCPA Negotiations

September 27, 2018
-
Market Access News
-
Posted by MORSE Team
Read More →
Read More →
Biosimilars - Info and details on - Page 2 of 3 - MORSE Consulting Inc.